Status:

COMPLETED

Human Transdermal Vitamin D Supplement Study

Lead Sponsor:

King's College London

Collaborating Sponsors:

Vitamax Wholesalers LLP

Conditions:

Vitamin D Supplementation

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Despite the wide availability of vitamin D supplements vitamin D deficiency remains a concerning global problem. It is hypothesised that hypothesize that vitamin D delivered via the skin will overcome...

Detailed Description

The primary objective of this study is to understand the ability of a vitamin D transdermal patch to provide effective vitamin D supplementation. To do this, the study team will identify, using a ques...

Eligibility Criteria

Inclusion

  • Healthy adults between 18 and 65 years of age
  • Suspected low vitamin D levels (defined as moderate or high risk using the Deschasaux questionnaire (10))
  • Written informed consent for study participation.
  • Willingness to comply with all study requirements.
  • Competent use of English language.

Exclusion

  • Patients unable to give informed consent.
  • The use of vitamin D supplements 4 weeks prior to the commencement of the study (and unwilling to washout).
  • Pregnancy
  • Those with parathyroid, thyroid, or calcium disorders, sarcoidosis, a requirement for calcium channel blockers, Type I diabetes, and concurrent active malignancies.
  • Those who have been diagnosed with vitamin D deficiency by a GP in the last 3 months using a blood test.
  • Those who have been diagnosed with vitamin D deficiency by a GP in the last 6 months using a blood test and have not taken any vitamin D supplements.

Key Trial Info

Start Date :

October 23 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 10 2024

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT06098846

Start Date

October 23 2023

End Date

September 10 2024

Last Update

August 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Pharmaceutical Science, King's College London

London, London, United Kingdom, SE19NH